It’s not just about where someone lives: educating student social workers about housing-related matters to promote an understanding of social justice

The links between housing and wellbeing are well established, and yet failings of current UK policy and practice can result in severely limited and inappropriate accommodation options for those in greatest need. Access to appropriate and affordable housing should therefore be a key area of concern for social work professionals: such access is closely linked to social justice and the promotion of human rights. Nevertheless, there is a paucity of detailed research on the links between housing and social work practice, and practitioners have reported feeling ill-equipped to support service-users with housing related needs. This paper draws on the illustrative example of a teaching session developed by the authors to argue that educating social work students about housing related matters not only reduces this reported practice knowledge gap, but may also develop their understanding of social justice. In addition to supporting calls for further research, the authors therefore encourage those involved in social work education to ensure that practice in the context of housing related needs is covered clearly within the curriculum

Restoring native ecosystems in urban Auckland: urban soils, isolation, and weeds as impediments to forest establishment

New Zealand urban environments are currently dominated by exotic plant species. Restoring native vegetation and its associated native biodiversity in these landscapes is desirable for both cultural and ecological reasons. We report on the first four years of an ongoing vegetation restoration experiment in Waitakere City, Auckland, that addresses four challenges to urban restoration: weeds, Anthropic Soils, attraction of frugivorous birds, and patch isolation. Nine commonly planted native species, grouped separately into wind- and bird-dispersed species, were planted across four sites increasingly isolated from native bush patches, using two site preparation methods. By year three, woody weeds >50 cm tall had established with an average density of 1.7 plant m across all sites. This was more than 17 times denser than all established wild native woody seedlings of any height. One of our establishment methods, sparse planting with mulch, resulted in higher native plant survival and faster plant growth. However, after 4 years, the more intensive method, dense planting and ripping of the soil, resulted in a denser canopy and a 2.8-fold reduction in woody weed establishment. The typically urban soils of all sites were highly modified, with substantial variation in compaction, ponding risk, and fertility over distances of 5-15 m. Several, but not all, species were detrimentally affected by soil compaction and ponding. Many bird-dispersed species, both native and non-native, colonised the experiment, although this did not differ between plots with planted wind-dispersed and bird-dispersed species, perhaps due to the small size of these plots. Site colonisation by native species was particularly high at sites ≤ 100 m from existing native vegetation, suggesting that even small patches of native vegetation in urban landscapes will be valuable as seed sources for accelerating native plant establishment at nearby receptive sites © New Zealand Ecological Society

COVID-19: Global radiation oncology's targeted response for pandemic preparedness

As the global COVID-19 pandemic escalates there is a need within radiation oncology to work to support our patients in the best way possible. Measures are required to reduce infection spread between patients and within the workforce. Departments need contingency planning to create capacity and continue essential treatments despite a reduced workforce. The #radonc community held an urgent online journal club on Twitter in March 2020 to discuss these issues and create some consensus on crucial next steps. There were 121 global contributors. This document summarises these discussions around themes of infection prevention, rationalisation of workload and working practice in the presence of infection

Do drugs offering only PFS maintain quality of life sufficiently from a patient's perspective? Results from AVALPROFS (Assessing the 'VALue' to patients of PROgression Free Survival) study.

PURPOSE: Trials of novel drugs used in advanced disease often show only progression-free survival or modest overall survival benefits. Hypothetical studies suggest that stabilisation of metastatic disease and/or symptom burden are worth treatment-related side effects. We examined this premise contemporaneously using qualitative and quantitative methods. METHODS: Patients with metastatic cancers expected to live > 6 months and prescribed drugs aimed at cancer control were interviewed: at baseline, at 6 weeks, at progression, and if treatment was stopped for toxicity. They also completed Functional Assessment of Cancer Therapy (FACT-G) plus Anti-Angiogenesis (AA) subscale questionnaires at baseline then monthly for 6 months. RESULTS: Ninety out of 120 (75%) eligible patients participated: 41 (45%) remained on study for 6 months, 36 progressed or died, 4 had treatment breaks, and 9 withdrew due to toxicity. By 6 weeks, 66/69 (96%) patients were experiencing side effects which impacted their activities. Low QoL scores at baseline did not predict a higher risk of death or dropout. At 6-week interviews, as the side effect severity increased, patients were significantly less inclined to view the benefit of cancer control as worthwhile (X2 = 50.7, P < 0.001). Emotional well-being initially improved from baseline by 10 weeks, then gradually returned to baseline levels. CONCLUSION: Maintaining QoL is vital to most patients with advanced cancer so minimising treatment-related side effects is essential. As side effect severity increased, drugs that controlled cancer for short periods were not viewed as worthwhile. Patients need to have the therapeutic aims of further anti-cancer treatment explained honestly and sensitively

First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)

Background: Oral temozolomide has shown similar efficacy to dacarbazine in phase III trials with median progression-free survival (PFS) of 2.1 months. Bevacizumab has an inhibitory effect on the proliferation of melanoma and sprouting endothelial cells. We evaluated the addition of bevacizumab to temozolomide to improve efficacy in stage IV melanoma. Patients and methods: Previously untreated metastatic melanoma patients with Eastern Cooperative Oncology Group performance status of two or more were treated with temozolomide 150 mg/m2 days 1-7 orally and bevacizumab 10 mg/kg body weight i.v. day 1 every 2 weeks until disease progression or unacceptable toxicity. The primary end point was disease stabilisation rate [complete response (CR), partial response (PR) or stable disease (SD)] at week 12 (DSR12); secondary end points were best overall response, PFS, overall survival (OS) and adverse events. Results: Sixty-two patients (median age 59 years) enrolled at nine Swiss centres. DSR12 was 52% (PR: 10 patients and SD: 22 patients). Confirmed overall response rate was 16.1% (CR: 1 patient and PR: 9 patients). Median PFS and OS were 4.2 and 9.6 months. OS (12.0 versus 9.2 months; P = 0.014) was higher in BRAF V600E wild-type patients. Conclusions: The primary end point was surpassed showing promising activity of this bevacizumab/temozolomide combination with a favourable toxicity profile. Response and OS were significantly higher in BRAF wild-type patient

An International Expert Delphi Consensus to Develop Dedicated Geriatric Radiation Oncology Curriculum Learning Outcomes.

PURPOSE: The management of older adults with cancer is rapidly becoming a significant challenge in radiation oncology (RO) practice. The education of future radiation oncologists in geriatric oncology is fundamental to ensuring that older adults receive high-quality care. Currently RO trainees receive little training and education in geriatric oncology. The objective of this study was to define core geriatric RO curriculum learning outcomes relevant to RO trainees worldwide. METHODS AND MATERIALS: A 2-stage modified Delphi consensus was conducted. Stage 1 involved the formation of an expert reference panel (ERP) of multiprofessional experts in geriatric oncology and/or RO and the compilation of a potential geriatric RO learning outcomes set. Stage 2 involved 3 iterative rounds: round 1 and round 2 (both online surveys), and an intervening ERP round. These aimed at identifying and refining ideal geriatric RO learning outcomes. Invited participants for round 1 and 2 included oncology health care professionals with expertise across RO, geriatric oncology, and/or education and consumers. Predefined Delphi consensus definitions were applied to the results of rounds 1 and 2. RESULTS: An ERP of 11 experts in geriatric oncology and/or RO was formed. Seventy potential knowledge- and skill-based learning outcomes were identified. In round 1, 103 of 179 invited eligible Delphi participants completed the survey (58% response rate). The ERP round was conducted, resulting in the exclusion of 28 learning outcomes. In round 2, 54 of 103 completed the survey (52% response rate). This identified a final total of 33 geriatric RO learning outcomes. CONCLUSIONS: The geriatric RO learning outcomes described in this study form an international consensus that can inform RO training bodies worldwide. This represents the first fundamental step in developing a global educational framework aimed at improving RO trainee knowledge and skills in geriatric oncology